Unknown PHASE4 INTERVENTIONAL 1-arm NCT02490956

Diagnostic Immunization With Rabies Vaccine in Patients With PID

Diagnostic Immunization With Rabies Vaccine in Patients With Primary Immunodeficiency Disorders

Sponsor: Chulalongkorn University

Interventions Verorab® (PVRV; Purified Vero Cell Vaccine)

Updated 6 times since 2017 Last updated: Jul 2, 2015 Started: Apr 30, 2015 Primary completion: Sep 30, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02490956, this PHASE4 trial focuses on Primary Immunodeficiency and remains ongoing. Sponsored by Chulalongkorn University, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Aug 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Aug 2017 [monthly]

Recruiting PHASE4

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chulalongkorn University

Data source: Chulalongkorn University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand